TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy

Clinical Trial Site, Aurora, Colorado, United States

Clinical Trial Site, Chicago, Illinois, United States

Clinical Trial Site, Baltimore, Maryland, United States

Clinical Trial Site, Boston, Massachusetts, United States

Clinical Trial Site, Rochester, Minnesota, United States

Clinical Trial Site, New York, New York, United States

Clinical Trial Site, Chapel Hill, North Carolina, United States

Clinical Trial Site, Dallas, Texas, United States

Clinical Trial Site, Darlinghurst, Australia

Clinical Trial Site, São Paulo, Brazil

Clinical Trial Site, Égkomi, Cyprus

Clinical Trial Site, Créteil, France

Clinical Trial Site, Le Kremlin-Bicêtre, France

Clinical Trial Site, Marseille, France

Clinical Trial Site, Athens, Greece

Clinical Trial Site, Heraklion, Greece

Clinical Trial Site, Florence, Italy

Clinical Trial Site, Milan, Italy

Clinical Trial Site, Pavia, Italy

Clinical Trial Site, Suita, Japan

Clinical Trial Site, Kuala Lumpur, Malaysia

Clinical Trial Site, Porto, Portugal

Clinical Trial Site, Seoul, South Korea

Clinical Trial Site, Seoul, South Korea

Clinical Trial Site, Stockholm, Sweden

Clinical Trial Site, Umeå, Sweden

Clinical Trial Site, Taipei, Taiwan

Clinical Trial Site, Taipei, Taiwan

Clinical Trial Site, Taoyuan City, Taiwan